Forbion Capital Partners

Forbion Capital Partners

Forbion Capital Partners

Forbion Capital Partners invests in Life Sciences and Biomedical Technology companies developing worldclass drugs and technologies, with a clear focus on product development..
Type
B2b
Founded
2007
Follow us
03 Jun 2020
03 Apr 2019
$50,000,000
Venture capital (Series A)
29 Aug 2018

KaNDy Therapeutics Raises £25M in Series C Financing

FinSMEs
+2
07 Feb 2017

Prexton Therapeutics, participated by Ysios Capital, Series B financing round raises € 29 millions to advance its novel Parkinson’s therapeutic.es

capital-riesgo
+1
05 Jan 2017
£23,000,000
Venture capital (Series B)

NeRRE Therapeutics picks up Series B funds

PE Hub
+2
15 Jun 2016

Allecra Therapeutics Announces €22 Million Series B Financing

prnewswire
+1
07 Jan 2016
$60,000,000
Venture capital (Series B)

Exosome Diagnostics Completes $60 Million Series B Financing

businesswire
+2
11 Mar 2014
$27,000,000
Venture capital (Series B)

Exosome Diagnostics raises USD 27m in Series B Financing Partners AG

b-to-v
+1
25 Jul 2012
04 Feb 2011